Intermittent exposure to doxorubicin in vitro selects for multifactorial non-P-glycoprotein-associated multidrug resistance in RPMI 8226 human myeloma cells
Beat Wyler, Ying Shao, Erasmus Schneider, Maurizio Cianfriglia, Rik J. Scheper, Beat M. Frey, Frank Gieseler, Luzius Schmid, Peter R. Twentyman, Manfred Lehnert*
Dive into the research topics of 'Intermittent exposure to doxorubicin in vitro selects for multifactorial non-P-glycoprotein-associated multidrug resistance in RPMI 8226 human myeloma cells'. Together they form a unique fingerprint.